Stories
250 words
2
Entries

Stories

Implementation of QR code-based drug authentication

2 entries over 4 days, from 26 June 2026 to 29 June 2026.

01
26 June

QR code framework for drugs expanded

  • The Union Health Ministry has amended the Drugs Rules, 1945, to expand the scope of Schedule H2.
  • The amendment mandates a QR code-based track-and-trace framework for specific drug categories.
  • Categories included under Schedule H2: all vaccines, antimicrobials, narcotic and psychotropic drugs (under NDPS Act, 1985), and all anti-cancer drugs.
  • Manufacturers must affix QR codes on primary packaging or secondary packaging if space is insufficient.
  • QR code data requirements: unique product identification code, generic and brand names, manufacturer details, batch number, manufacturing and expiry dates, manufacturing licence number, and excipient details.
  • The primary objective of this framework is to curb the distribution of spurious medicines and ensure supply chain verification.
02
29 June

Regulation of Schedule H2 drugs

  • Health Ministry expanded Schedule H2 drug regulation from a curated brand list to entire therapeutic classes.
  • Schedule H2 requires barcodes or QR codes on packaging for authenticity verification.
  • Encoded data includes product identifier, manufacturing license number, and batch number.
  • Objective: Improve tracking of defective batches, combat counterfeit medicines, and address quality control concerns from US FDA and European Medicines Agency.
  • Counterfeit medicines pose risks of antimicrobial resistance (AMR) due to sub-therapeutic dosing.
  • Jan Vishwas Act 2026 distinguishes between procedural and substantial non-compliance.
  • Implementation challenges include: need for a real-time state-managed database, interoperable software, scanning infrastructure, and protection of sensitive prescription data.
  • MSME manufacturers face increased compliance burdens due to new packaging and IT requirements.

Questions from this story

Newest first. A story that ran for 4 days is exactly the kind the mains paper asks about as one question.

  1. Discuss the significance of the shift from brand-based to therapeutic class-based regulation of Schedule H2 drugs in ensuring pharmaceutical quality and patient safety in India. 150 words · 29 June
  2. The integration of digital tracking systems like QR codes in pharmaceutical packaging is essential for global supply chain compliance. Critically analyze the challenges in implementing such a framework, particularly regarding MSME capacity, data governance, and the need for a robust digital infrastructure. 250 words · 29 June
  3. Discuss the significance of the QR code-based track-and-trace framework in ensuring the integrity of the pharmaceutical supply chain in India. 150 words · 26 June
  4. The integration of digital technologies in the regulation of essential medicines is a critical step towards public health security. Elaborate on how the expansion of Schedule H2 under the Drugs Rules, 1945, addresses the challenge of spurious drugs in the Indian market. 250 words · 26 June